Keros Therapeutics (KROS) Net Equity Issued and Repurchased (2019 - 2025)
Keros Therapeutics (KROS) posted Net Equity Issued and Repurchased of $12,000 for Q4 2025, down 99.5% from $2.45 million a year earlier and down 89.7% from the prior quarter.
Powered by 
Analysis
Keros Therapeutics (KROS) Net Equity Issued and Repurchased (2019 - 2025) Analysis & Trends
For FY2025, Keros Therapeutics' Net Equity Issued and Repurchased came in at $150,000, down 98.8% from FY2024.
- Annual Net Equity Issued and Repurchased shows a five-year compound annual growth rate of -72.9% (FY2020 to FY2025).
- In prior years, Keros Therapeutics' Net Equity Issued and Repurchased was $12.14 million in FY2024 (+276.5%), $3.23 million in FY2023 (+294.3%), $818,000 in FY2022 (+115.8%) and $379,000 in FY2021 (-99.6%).
- Quarterly Net Equity Issued and Repurchased has run from a low of -$105.2 million in Q2 2023 to a high of $107.31 million in Q1 2023 over five years.
- On a year-over-year basis, Net Equity Issued and Repurchased has declined in each of the last four quarters, with an average decline of 7.7% over the last seven quarters.
- The strongest year-over-year quarter for Net Equity Issued and Repurchased in the past five years was Q3 2024, with growth of 224.1%; the weakest was Q1 2025, with a decline of 99.9%.
- According to Business Quant data, Net Equity Issued and Repurchased for the three prior quarters was $117,000 (Q3 2025), $17,000 (Q2 2025) and $4,000 (Q1 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,230.11 Bn | 1,198.70 Bn | 19.71 Bn | -1.60 Bn |
| 2 | Johnson & Johnson | 644.39 Bn | 564.25 Bn | 17.30 Bn | -966.00 Mn |
| 3 | AbbVie | 503.52 Bn | 476.68 Bn | 12.70 Bn | -9.00 Mn |
| 4 | Merck | 363.29 Bn | 317.72 Bn | 12.21 Bn | -714.00 Mn |
| 5 | Novartis Ag | 298.23 Bn | 262.62 Bn | 11.24 Bn | -1.20 Bn |
| 6 | Astrazeneca | 267.53 Bn | 241.29 Bn | 12.86 Bn | 6.00 Mn |
| 7 | Amgen | 241.80 Bn | 197.20 Bn | 7.24 Bn | - |
| 8 | Gilead Sciences | 195.07 Bn | 169.19 Bn | 6.22 Bn | -346.00 Mn |
| 9 | Pfizer | 173.33 Bn | 120.28 Bn | 10.94 Bn | - |
| 10 | Keros Therapeutics | 225.04 Mn | -1.70 Bn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 127,000.00 |
| Sep 30, 2025 | 140,000.00 |
| Jun 30, 2025 | 17,000.00 |
| Mar 31, 2025 | 4,000.00 |
| Dec 31, 2024 | 2.45 Mn |
| Sep 30, 2024 | 1.01 Mn |
| Jun 30, 2024 | 2.97 Mn |
| Mar 31, 2024 | 5.72 Mn |
| Dec 31, 2023 | 804,000.00 |
| Sep 30, 2023 | 311,000.00 |
| Jun 30, 2023 | -105.57 Mn |
| Mar 31, 2023 | 107.68 Mn |
| Dec 31, 2022 | -58.08 Mn |
| Sep 30, 2022 | 48.58 Mn |
| Jun 30, 2022 | 10.19 Mn |
| Mar 31, 2022 | 118,000.00 |
| Dec 31, 2021 | 245,000.00 |
| Sep 30, 2021 | 35,000.00 |
| Jun 30, 2021 | 57,000.00 |
| Mar 31, 2021 | 42,000.00 |
API Access
Keros Therapeutics Net Equity Issued and Repurchased API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=KROS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-equity-issued-and-repurchased", "ticker": "KROS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=KROS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();